This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
ALKBH2 inhibition alleviates malignancy in colorectal cancer by regulating BMI1-mediated activation of NF-κB pathway
World Journal of Surgical Oncology Open Access 10 December 2020
-
The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells
Blood Cancer Journal Open Access 17 February 2017
-
Upregulation of the proto-oncogene Bmi-1 predicts a poor prognosis in pediatric acute lymphoblastic leukemia
BMC Cancer Open Access 25 January 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sparmann A, van Lohuizen M . Polycomb silencers control cell fate, development and cancer. Nature Reviews Cancer 2006; 6: 846–856.
Lessard J, Sauvageau G . Bmi-1 determines the proliferative capacity of normal and leukemic stem cells. Nature 2003; 423: 255–260.
Mihara K, Chowdhury M, Nakaju N, Hidani S, Ihara A, Hyodo H et al. Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis. Blood 2006; 107: 305–308.
Cheson BD, Bennett JM, Kopecky KJ, Büchner T, Willman CL, Estey EH et al. Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 2003; 21: 4642–4649.
Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325–4336.
Kiyoi H, Naoe T, Nakano Y, Yokota S, Minami S, Miyawaki S et al. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 1999; 93: 3074–3080.
Schnittger S, Wormann B, Hiddemann W, Griesinger F . Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood 1998; 92: 1728–1734.
Sawa M, Yamamoto K, Yokozawa T, Kiyoi H, Hishida A, Kajiguchi T et al. BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. Int J Hematol 2005; 82: 42–47.
Acknowledgements
We thank Dr Hideo Hyodo, Dr Hironori Harada, Dr Taiichi Kyo, Dr Hideo Tanaka, Dr Akira Sakai, for their help to collect patients’ sample. We also thank Nanae Nakaju, Sachiko Fukumoto, and Ryoko Matsumoto for their excellent technical support and Mohammad Doki for his help in data analysis.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Rights and permissions
About this article
Cite this article
Chowdhury, M., Mihara, K., Yasunaga, S. et al. Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia. Leukemia 21, 1116–1122 (2007). https://doi.org/10.1038/sj.leu.2404623
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404623
This article is cited by
-
ALKBH2 inhibition alleviates malignancy in colorectal cancer by regulating BMI1-mediated activation of NF-κB pathway
World Journal of Surgical Oncology (2020)
-
The Prognostic Significance of the BMI-1 and BAALC Genes in Adult Patients with Acute Myeloid Leukemia
Indian Journal of Hematology and Blood Transfusion (2020)
-
Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemia
Leukemia (2018)
-
Upregulation of the proto-oncogene Bmi-1 predicts a poor prognosis in pediatric acute lymphoblastic leukemia
BMC Cancer (2017)
-
The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells
Blood Cancer Journal (2017)